Background: Genital warts (condyloma acuminatum) remain one of the most commonly
reported sexually transmitted infections (STI) worldwide. Most genital warts are caused by …

Objectives Estimate the prevalence of genital warts (GW) and GW-related healthcare
resource use and costs among male and female patients seeking treatment in South Korea …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

In Australia, school-based human papillomavirus (HPV) vaccination was introduced initially
for girls in 2007, and then also for boys in 2013. While studies have shown declines in the …

Introduction Genital warts are caused by infection with human papillomavirus (HPV) and are
associated with significant morbidity. Primary prevention of genital warts is possible through …

Background Human papillomavirus (HPV), primarily genotypes 6 and 11, cause the majority
of cases of anogenital warts (AGW). Although benign, AGW are associated with a substantial …

Objectives Australia introduced a nationwide human papillomavirus (HPV) vaccination
programme for women aged 12–26 years in 2007 and has implemented various chlamydia …

Background Australia provided free quadrivalent human papillomavirus vaccines to 12–18-
year-old girls and women aged≤ 26 years from mid-2007 until the end of 2009. After this …

Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …